This invention targets the energy production that is need for viral replication and cancer cell growth by blocking glycolysis and by decreasing pyruvate that is available to undergo metabolism within the Krebs cycle with administration of a medication comprised of 2-deoxy-D-glucose (2DG) and D-lactic acid dimer (DLAD).